><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopf</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Nobs</surname><given-names>SP</given-names></name></person-group>
<article-title>The development and function of lung-resident macrophages and dendritic cells</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>16</volume>:<fpage>36</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3052</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durbin</surname><given-names>RK</given-names></name><name><surname>Kotenko</surname><given-names>SV</given-names></name><name><surname>Durbin</surname><given-names>JE</given-names></name></person-group>. <article-title>Interferon induction and function at the mucosal surface</article-title>. <source>Immunol Rev</source> (<year>2013</year>) <volume>255</volume>:<fpage>25</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12101</pub-id><?supplied-pmid 23947345?><pub-id pub-id-type="pmid">23947345</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Navajas</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>David</surname><given-names>M</given-names></name><name><surname>Raz</surname><given-names>E</given-names></name></person-group>. <article-title>Immunomodulatory functions of type I interferons</article-title>. <source>Nat Rev Immunol</source> (<year>2012</year>) <volume>12</volume>:<fpage>125</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1038/nri3133</pub-id><?supplied-pmid 22222875?><pub-id pub-id-type="pmid">22222875</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiecki</surname><given-names>M</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group>. <article-title>Type I interferons: diversity of sources, production pathways and effects on immune responses</article-title>. <source>Curr Opin Virol</source> (<year>2011</year>) <volume>1</volume>:<fpage>463</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1016/j.coviro.2011.10.026</pub-id><?supplied-pmid 22440910?><pub-id pub-id-type="pmid">22440910</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>Terczy&#x00144;ska-Dyla</surname><given-names>E</given-names></name><name><surname>Hartmann</surname><given-names>R</given-names></name></person-group>. <article-title>Guarding the frontiers: the biology of type III interferons</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>:<fpage>802</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3212</pub-id><?supplied-pmid 26194286?><pub-id pub-id-type="pmid">26194286</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egli</surname><given-names>A</given-names></name><name><surname>Santer</surname><given-names>DM</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>D</given-names></name><name><surname>Barakat</surname><given-names>K</given-names></name><name><surname>Syedbasha</surname><given-names>M</given-names></name><name><surname>Vollmer</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>IL-28B is a key regulator of B- and T-cell vaccine responses against influenza</article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>:<fpage>e1004556</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1004556</pub-id><?supplied-pmid 25503988?><pub-id pub-id-type="pmid">25503988</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokunina-Olsson</surname><given-names>L</given-names></name><name><surname>Muchmore</surname><given-names>B</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Pfeiffer</surname><given-names>RM</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Dickensheets</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus</article-title>. <source>Nat Genet</source> (<year>2013</year>) <volume>45</volume>:<fpage>164</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1038/ng.2521</pub-id><?supplied-pmid 23291588?><pub-id pub-id-type="pmid">23291588</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F</given-names></name><name><surname>Mayer-Barber</surname><given-names>K</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group>. <article-title>Type I interferons in infectious disease</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>87</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1038/nri3787</pub-id><?supplied-pmid 25614319?><pub-id pub-id-type="pmid">25614319</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group>. <article-title>Toll-like receptors and their crosstalk with other innate receptors in infection and immunity</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<fpage>637</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.006</pub-id><?supplied-pmid 21616434?><pub-id pub-id-type="pmid">21616434</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loo</surname><given-names>Y-M</given-names></name><name><surname>Gale</surname><given-names>M</given-names></name></person-group>. <article-title>Immune signaling by RIG-I-like receptors</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<fpage>680</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.003</pub-id><?supplied-pmid 21616437?><pub-id pub-id-type="pmid">21616437</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goubau</surname><given-names>D</given-names></name><name><surname>Deddouche</surname><given-names>S</given-names></name><name><surname>Reis e Sousa</surname><given-names>C</given-names></name></person-group>. <article-title>Cytosolic sensing of viruses</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>855</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.05.007</pub-id><?supplied-pmid 23706667?><pub-id pub-id-type="pmid">23706667</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brubaker</surname><given-names>SW</given-names></name><name><surname>Bonham</surname><given-names>KS</given-names></name><name><surname>Zanoni</surname><given-names>I</given-names></name><name><surname>Kagan</surname><given-names>JC</given-names></name></person-group>. <article-title>Innate immune pattern recognition: a cell biological perspective</article-title>. <source>Annu Rev Immunol</source> (<year>2015</year>) <volume>33</volume>:<fpage>257</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112240</pub-id><?supplied-pmid 25581309?><pub-id pub-id-type="pmid">25581309</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;rtler</surname><given-names>C</given-names></name><name><surname>Bowie</surname><given-names>AG</given-names></name></person-group>. <article-title>Innate immune detection of microbial nucleic acids</article-title>. <source>Trends Microbiol</source> (<year>2013</year>) <volume>21</volume>:<fpage>413</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.tim.2013.04.004</pub-id><?supplied-pmid 23726320?><pub-id pub-id-type="pmid">23726320</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>LAJ</given-names></name><name><surname>Golenbock</surname><given-names>D</given-names></name><name><surname>Bowie</surname><given-names>AG</given-names></name></person-group>. <article-title>The history of toll-like receptors &#x02013; redefining innate immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>:<fpage>453</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1038/nri3446</pub-id><?supplied-pmid 23681101?><pub-id pub-id-type="pmid">23681101</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Rowe</surname><given-names>DC</given-names></name><name><surname>Barnes</surname><given-names>BJ</given-names></name><name><surname>Caffrey</surname><given-names>DR</given-names></name><name><surname>Visintin</surname><given-names>A</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>198</volume>:<fpage>1043</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20031023</pub-id><?supplied-pmid 14517278?><pub-id pub-id-type="pmid">14517278</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Popova</surname><given-names>L</given-names></name><name><surname>Kwinn</surname><given-names>L</given-names></name><name><surname>Haynes</surname><given-names>LM</given-names></name><name><surname>Jones</surname><given-names>LP</given-names></name><name><surname>Tripp</surname><given-names>RA</given-names></name><etal/></person-group>
<article-title>Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus</article-title>. <source>Nat Immunol</source> (<year>2000</year>) <volume>1</volume>:<fpage>398</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="doi">10.1038/80833</pub-id><?supplied-pmid 11062499?><pub-id pub-id-type="pmid">11062499</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goubau</surname><given-names>D</given-names></name><name><surname>Schlee</surname><given-names>M</given-names></name><name><surname>Deddouche</surname><given-names>S</given-names></name><name><surname>Pruijssers</surname><given-names>AJ</given-names></name><name><surname>Zillinger</surname><given-names>T</given-names></name><name><surname>Goldeck</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5&#x02019;-diphosphates</article-title>. <source>Nature</source> (<year>2014</year>) <volume>514</volume>:<fpage>372</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature13590</pub-id><?supplied-pmid 25119032?><pub-id pub-id-type="pmid">25119032</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornung</surname><given-names>V</given-names></name><name><surname>Ellegast</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Brz&#x000f3;zka</surname><given-names>K</given-names></name><name><surname>Jung</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>5&#x02019;-Triphosphate RNA is the ligand for RIG-I</article-title>. <source>Science</source> (<year>2006</year>) <volume>314</volume>:<fpage>994</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1126/science.1132505</pub-id><?supplied-pmid 17038590?><pub-id pub-id-type="pmid">17038590</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pichlmair</surname><given-names>A</given-names></name><name><surname>Schulz</surname><given-names>O</given-names></name><name><surname>Tan</surname><given-names>CP</given-names></name><name><surname>N&#x000e4;slund</surname><given-names>TI</given-names></name><name><surname>Liljestr&#x000f6;m</surname><given-names>P</given-names></name><name><surname>Weber</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>RIG-I-mediated antiviral responses to single-stranded RNA bearing 5&#x02019;-phosphates</article-title>. <source>Science</source> (<year>2006</year>) <volume>314</volume>:<fpage>997</fpage>&#x02013;<lpage>1001</lpage>.<pub-id pub-id-type="doi">10.1126/science.1132998</pub-id><?supplied-pmid 17038589?><pub-id pub-id-type="pmid">17038589</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruns</surname><given-names>AM</given-names></name><name><surname>Leser</surname><given-names>GP</given-names></name><name><surname>Lamb</surname><given-names>RA</given-names></name><name><surname>Horvath</surname><given-names>CM</given-names></name></person-group>. <article-title>The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly</article-title>. <source>Mol Cell</source> (<year>2014</year>) <volume>55</volume>:<fpage>771</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.molcel.2014.07.003</pub-id><?supplied-pmid 25127512?><pub-id pub-id-type="pmid">25127512</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Cong</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation</article-title>. <source>Science</source> (<year>2015</year>) <volume>347</volume>(<issue>6227</issue>):<fpage>aaa2630</fpage>.<pub-id pub-id-type="doi">10.1126/science.aaa2630</pub-id><?supplied-pmid 25636800?><pub-id pub-id-type="pmid">25636800</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Hur</surname><given-names>S</given-names></name></person-group>. <article-title>How RIG-I like receptors activate MAVS</article-title>. <source>Curr Opin Virol</source> (<year>2015</year>) <volume>12</volume>:<fpage>91</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.coviro.2015.04.004</pub-id><?supplied-pmid 25942693?><pub-id pub-id-type="pmid">25942693</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>KJ</given-names></name><name><surname>Kawagoe</surname><given-names>T</given-names></name><name><surname>Koyama</surname><given-names>S</given-names></name><name><surname>Matsui</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>H</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines</article-title>. <source>Nature</source> (<year>2008</year>) <volume>451</volume>:<fpage>725</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nature06537</pub-id><?supplied-pmid 18256672?><pub-id pub-id-type="pmid">18256672</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paludan</surname><given-names>SR</given-names></name><name><surname>Bowie</surname><given-names>AG</given-names></name></person-group>
<article-title>Immune sensing of DNA</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>870</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.05.004</pub-id><pub-id pub-id-type="pmid">23706668</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>Y-H</given-names></name><name><surname>Macmillan</surname><given-names>JB</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>. <article-title>RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway</article-title>. <source>Cell</source> (<year>2009</year>) <volume>138</volume>:<fpage>576</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2009.06.015</pub-id><?supplied-pmid 19631370?><pub-id pub-id-type="pmid">19631370</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schattgen</surname><given-names>SA</given-names></name><name><surname>Gao</surname><given-names>G</given-names></name><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name></person-group>. <article-title>Cutting edge: DNA in the lung microenvironment during influenza virus infection tempers inflammation by engaging the DNA sensor AIM2</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>196</volume>:<fpage>29</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1501048</pub-id><?supplied-pmid 26590313?><pub-id pub-id-type="pmid">26590313</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>. <article-title>STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway</article-title>. <source>Sci Signal</source> (<year>2012</year>) <volume>5</volume>:<fpage>ra20</fpage>.<pub-id pub-id-type="doi">10.1126/scisignal.2002521</pub-id><?supplied-pmid 22394562?><pub-id pub-id-type="pmid">22394562</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Du</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>. <article-title>Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>:<fpage>786</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1126/science.1232458</pub-id><?supplied-pmid 23258413?><pub-id pub-id-type="pmid">23258413</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ablasser</surname><given-names>A</given-names></name><name><surname>Goldeck</surname><given-names>M</given-names></name><name><surname>Cavlar</surname><given-names>T</given-names></name><name><surname>Deimling</surname><given-names>T</given-names></name><name><surname>Witte</surname><given-names>G</given-names></name><name><surname>R&#x000f6;hl</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>cGAS produces a 2&#x02019;-5&#x02019;-linked cyclic dinucleotide second messenger that activates STING</article-title>. <source>Nature</source> (<year>2013</year>) <volume>498</volume>:<fpage>380</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/nature12306</pub-id><pub-id pub-id-type="pmid">23722158</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>:<fpage>826</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1126/science.1229963</pub-id><pub-id pub-id-type="pmid">23258412</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ablasser</surname><given-names>A</given-names></name><name><surname>Schmid-Burgk</surname><given-names>JL</given-names></name><name><surname>Hemmerling</surname><given-names>I</given-names></name><name><surname>Horvath</surname><given-names>GL</given-names></name><name><surname>Schmidt</surname><given-names>T</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP</article-title>. <source>Nature</source> (<year>2013</year>) <volume>503</volume>:<fpage>530</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/nature12640</pub-id><?supplied-pmid 24077100?><pub-id pub-id-type="pmid">24077100</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crotta</surname><given-names>S</given-names></name><name><surname>Davidson</surname><given-names>S</given-names></name><name><surname>Mahlakoiv</surname><given-names>T</given-names></name><name><surname>Desmet</surname><given-names>CJ</given-names></name><name><surname>Buckwalter</surname><given-names>MR</given-names></name><name><surname>Albert</surname><given-names>ML</given-names></name><etal/></person-group>
<article-title>Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003773</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003773</pub-id><?supplied-pmid 24278020?><pub-id pub-id-type="pmid">24278020</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group>. <article-title>The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>:<fpage>373</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1863</pub-id><?supplied-pmid 20404851?><pub-id pub-id-type="pmid">20404851</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>A</given-names></name><name><surname>Pillai</surname><given-names>PS</given-names></name></person-group>. <article-title>Innate immunity to influenza virus infection</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>:<fpage>315</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1038/nri3665</pub-id><?supplied-pmid 24762827?><pub-id pub-id-type="pmid">24762827</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goritzka</surname><given-names>M</given-names></name><name><surname>Makris</surname><given-names>S</given-names></name><name><surname>Kausar</surname><given-names>F</given-names></name><name><surname>Durant</surname><given-names>LR</given-names></name><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Kumagai</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>:<fpage>699</fpage>&#x02013;<lpage>714</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20140825</pub-id><?supplied-pmid 25897172?><pub-id pub-id-type="pmid">25897172</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platanias</surname><given-names>LC</given-names></name></person-group>. <article-title>Mechanisms of type-I- and type-II-interferon-mediated signalling</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>:<fpage>375</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1038/nri1604</pub-id><?supplied-pmid 15864272?><pub-id pub-id-type="pmid">15864272</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoggins</surname><given-names>JW</given-names></name><name><surname>Wilson</surname><given-names>SJ</given-names></name><name><surname>Panis</surname><given-names>M</given-names></name><name><surname>Murphy</surname><given-names>MY</given-names></name><name><surname>Jones</surname><given-names>CT</given-names></name><name><surname>Bieniasz</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>A diverse range of gene products are effectors of the type I interferon antiviral response</article-title>. <source>Nature</source> (<year>2011</year>) <volume>472</volume>:<fpage>481</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature09907</pub-id><pub-id pub-id-type="pmid">21478870</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoggins</surname><given-names>JW</given-names></name></person-group>. <article-title>Interferon-stimulated genes: roles in viral pathogenesis</article-title>. <source>Curr Opin Virol</source> (<year>2014</year>) <volume>6</volume>:<fpage>40</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.coviro.2014.03.006</pub-id><?supplied-pmid 24713352?><pub-id pub-id-type="pmid">24713352</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>GR</given-names></name><name><surname>Darnell</surname><given-names>JE</given-names></name></person-group>. <article-title>The JAK-STAT pathway at twenty</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>36</volume>:<fpage>503</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.03.013</pub-id><?supplied-pmid 22520844?><pub-id pub-id-type="pmid">22520844</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>WM</given-names></name><name><surname>Chevillotte</surname><given-names>MD</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name></person-group>. <article-title>Interferon-stimulated genes: a complex web of host defenses</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>513</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id><?supplied-pmid 24555472?><pub-id pub-id-type="pmid">24555472</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C</given-names></name><name><surname>Moraga</surname><given-names>I</given-names></name><name><surname>Levin</surname><given-names>D</given-names></name><name><surname>Krutzik</surname><given-names>PO</given-names></name><name><surname>Podoplelova</surname><given-names>Y</given-names></name><name><surname>Trejo</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Structural linkage between ligand discrimination and receptor activation by type I interferons</article-title>. <source>Cell</source> (<year>2011</year>) <volume>146</volume>:<fpage>621</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2011.06.048</pub-id><?supplied-pmid 21854986?><pub-id pub-id-type="pmid">21854986</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Weerd</surname><given-names>NA</given-names></name><name><surname>Vivian</surname><given-names>JP</given-names></name><name><surname>Nguyen</surname><given-names>TK</given-names></name><name><surname>Mangan</surname><given-names>NE</given-names></name><name><surname>Gould</surname><given-names>JA</given-names></name><name><surname>Braniff</surname><given-names>S-J</given-names></name><etal/></person-group>
<article-title>Structural basis of a unique interferon-&#x003b2; signaling axis mediated via the receptor IFNAR1</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>901</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2667</pub-id><?supplied-pmid 23872679?><pub-id pub-id-type="pmid">23872679</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>K</given-names></name><name><surname>Yanai</surname><given-names>H</given-names></name><name><surname>Negishi</surname><given-names>H</given-names></name><name><surname>Asagiri</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Mizutani</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>IRF-7 is the master regulator of type-I interferon-dependent immune responses</article-title>. <source>Nature</source> (<year>2005</year>) <volume>434</volume>:<fpage>772</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature03464</pub-id><?supplied-pmid 15800576?><pub-id pub-id-type="pmid">15800576</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mari&#x000e9;</surname><given-names>I</given-names></name><name><surname>Durbin</surname><given-names>JE</given-names></name><name><surname>Levy</surname><given-names>DE</given-names></name></person-group>
<article-title>Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7</article-title>. <source>EMBO J</source> (<year>1998</year>) <volume>17</volume>:<fpage>6660</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/emboj/17.22.6660</pub-id><pub-id pub-id-type="pmid">9822609</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivashkiv</surname><given-names>LB</given-names></name><name><surname>Donlin</surname><given-names>LT</given-names></name></person-group>
<article-title>Regulation of type I interferon responses</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>36</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1038/nri3581</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancho-Shimizu</surname><given-names>V</given-names></name><name><surname>P&#x000e9;rez de Diego</surname><given-names>R</given-names></name><name><surname>Jouanguy</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>S-Y</given-names></name><name><surname>Casanova</surname><given-names>J-L</given-names></name></person-group>. <article-title>Inborn errors of anti-viral interferon immunity in humans</article-title>. <source>Curr Opin Virol</source> (<year>2011</year>) <volume>1</volume>:<fpage>487</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/j.coviro.2011.10.016</pub-id><?supplied-pmid 22347990?><pub-id pub-id-type="pmid">22347990</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S-Y</given-names></name><name><surname>Boisson-Dupuis</surname><given-names>S</given-names></name><name><surname>Chapgier</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Bustamante</surname><given-names>J</given-names></name><name><surname>Puel</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense</article-title>. <source>Immunol Rev</source> (<year>2008</year>) <volume>226</volume>:<fpage>29</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00698.x</pub-id><?supplied-pmid 19161414?><pub-id pub-id-type="pmid">19161414</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciancanelli</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>SXL</given-names></name><name><surname>Luthra</surname><given-names>P</given-names></name><name><surname>Garner</surname><given-names>H</given-names></name><name><surname>Itan</surname><given-names>Y</given-names></name><name><surname>Volpi</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency</article-title>. <source>Science</source> (<year>2015</year>) <volume>348</volume>:<fpage>448</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1126/science.aaa1578</pub-id><?supplied-pmid 25814066?><pub-id pub-id-type="pmid">25814066</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>R</given-names></name><name><surname>Bont</surname><given-names>L</given-names></name><name><surname>Siezen</surname><given-names>CLE</given-names></name><name><surname>Hodemaekers</surname><given-names>HM</given-names></name><name><surname>Ermers</surname><given-names>MJ</given-names></name><name><surname>Doornbos</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes</article-title>. <source>J Infect Dis</source> (<year>2007</year>) <volume>196</volume>:<fpage>826</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1086/520886</pub-id><?supplied-pmid 17703412?><pub-id pub-id-type="pmid">17703412</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siezen</surname><given-names>CLE</given-names></name><name><surname>Bont</surname><given-names>L</given-names></name><name><surname>Hodemaekers</surname><given-names>HM</given-names></name><name><surname>Ermers</surname><given-names>MJ</given-names></name><name><surname>Doornbos</surname><given-names>G</given-names></name><name><surname>Van&#x02019;t Slot</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes</article-title>. <source>Pediatr Infect Dis J</source> (<year>2009</year>) <volume>28</volume>:<fpage>333</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1097/INF.0b013e31818e2aa9</pub-id><?supplied-pmid 19258923?><pub-id pub-id-type="pmid">19258923</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everitt</surname><given-names>AR</given-names></name><name><surname>Clare</surname><given-names>S</given-names></name><name><surname>Pertel</surname><given-names>T</given-names></name><name><surname>John</surname><given-names>SP</given-names></name><name><surname>Wash</surname><given-names>RS</given-names></name><name><surname>Smith</surname><given-names>SE</given-names></name><etal/></person-group>
<article-title>IFITM3 restricts the morbidity and mortality associated with influenza</article-title>. <source>Nature</source> (<year>2012</year>) <volume>484</volume>:<fpage>519</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1038/nature10921</pub-id><?supplied-pmid 22446628?><pub-id pub-id-type="pmid">22446628</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y-H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Peng</surname><given-names>Y-C</given-names></name><name><surname>Giannoulatou</surname><given-names>E</given-names></name><name><surname>Jin</surname><given-names>R-H</given-names></name><etal/></person-group>
<article-title>Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals</article-title>. <source>Nat Commun</source> (<year>2013</year>) <volume>4</volume>:<fpage>1418</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms2433</pub-id><?supplied-pmid 23361009?><pub-id pub-id-type="pmid">23361009</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>PS</given-names></name><name><surname>Molony</surname><given-names>RD</given-names></name><name><surname>Martinod</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Pang</surname><given-names>IK</given-names></name><name><surname>Tal</surname><given-names>MC</given-names></name><etal/></person-group>
<article-title>Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease</article-title>. <source>Science</source> (<year>2016</year>) <volume>352</volume>:<fpage>463</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1126/science.aaf3926</pub-id><?supplied-pmid 27102485?><pub-id pub-id-type="pmid">27102485</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciancanelli</surname><given-names>MJ</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>S-Y</given-names></name><name><surname>Casanova</surname><given-names>J-L</given-names></name></person-group>. <article-title>Host genetics of severe influenza: from mouse Mx1 to human IRF7</article-title>. <source>Curr Opin Immunol</source> (<year>2016</year>) <volume>38</volume>:<fpage>109</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2015.12.002</pub-id><?supplied-pmid 26761402?><pub-id pub-id-type="pmid">26761402</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group>. <article-title>Type I interferon: friend or foe?</article-title>
<source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>2053</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20101664</pub-id><?supplied-pmid 20837696?><pub-id pub-id-type="pmid">20837696</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goritzka</surname><given-names>M</given-names></name><name><surname>Durant</surname><given-names>LR</given-names></name><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Salek-Ardakani</surname><given-names>S</given-names></name><name><surname>Openshaw</surname><given-names>PJM</given-names></name><name><surname>Johansson</surname><given-names>C</given-names></name></person-group>
<article-title>Interferon-&#x003b1;/&#x003b2; receptor signaling amplifies early pro-inflammatory cytokine production in the lung during respiratory syncytial virus infection</article-title>. <source>J Virol</source> (<year>2014</year>) <volume>88</volume>:<fpage>6128</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00333-14</pub-id><pub-id pub-id-type="pmid">24648449</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>MH</given-names></name><name><surname>Torres-Dom&#x000ed;nguez</surname><given-names>LE</given-names></name><name><surname>Price</surname><given-names>PJR</given-names></name><name><surname>Brandm&#x000fc;ller</surname><given-names>C</given-names></name><name><surname>Kirschning</surname><given-names>CJ</given-names></name><name><surname>Sutter</surname><given-names>G</given-names></name></person-group>. <article-title>CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection</article-title>. <source>J Leukoc Biol</source> (<year>2016</year>) <volume>99</volume>:<fpage>1057</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.4MA0815-376RR</pub-id><?supplied-pmid 26992431?><pub-id pub-id-type="pmid">26992431</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>DB</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>. <article-title>Type I interferons in host defense</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>25</volume>:<fpage>373</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2006.08.007</pub-id><?supplied-pmid 16979569?><pub-id pub-id-type="pmid">16979569</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Amakawa</surname><given-names>R</given-names></name><name><surname>Inaba</surname><given-names>M</given-names></name><name><surname>Ikehara</surname><given-names>S</given-names></name><name><surname>Inaba</surname><given-names>K</given-names></name><name><surname>Fukuhara</surname><given-names>S</given-names></name></person-group>
<article-title>Differential regulation of human blood dendritic cell subsets by IFNs</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>166</volume>:<fpage>2961</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.166.5.2961</pub-id><pub-id pub-id-type="pmid">11207245</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bon</surname><given-names>A</given-names></name><name><surname>Etchart</surname><given-names>N</given-names></name><name><surname>Rossmann</surname><given-names>C</given-names></name><name><surname>Ashton</surname><given-names>M</given-names></name><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Gewert</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>:<fpage>1009</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1038/ni978</pub-id><?supplied-pmid 14502286?><pub-id pub-id-type="pmid">14502286</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouzaut</surname><given-names>A</given-names></name><name><surname>Garasa</surname><given-names>S</given-names></name><name><surname>Teijeira</surname><given-names>A</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>I</given-names></name><name><surname>Martinez-Forero</surname><given-names>I</given-names></name><name><surname>Suarez</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-&#x003b1;</article-title>. <source>Eur J Immunol</source> (<year>2010</year>) <volume>40</volume>:<fpage>3054</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201040523</pub-id><?supplied-pmid 21061437?><pub-id pub-id-type="pmid">21061437</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spadaro</surname><given-names>F</given-names></name><name><surname>Lapenta</surname><given-names>C</given-names></name><name><surname>Donati</surname><given-names>S</given-names></name><name><surname>Abalsamo</surname><given-names>L</given-names></name><name><surname>Barnaba</surname><given-names>V</given-names></name><name><surname>Belardelli</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>IFN-&#x003b1; enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing</article-title>. <source>Blood</source> (<year>2012</year>) <volume>119</volume>:<fpage>1407</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2011-06-363564</pub-id><?supplied-pmid 22184405?><pub-id pub-id-type="pmid">22184405</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>J</given-names></name><name><surname>Kalinke</surname><given-names>U</given-names></name><name><surname>Oxenius</surname><given-names>A</given-names></name></person-group>. <article-title>Regulation of antiviral T cell responses by type I interferons</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>231</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1038/nri3806</pub-id><?supplied-pmid 25790790?><pub-id pub-id-type="pmid">25790790</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asselin-Paturel</surname><given-names>C</given-names></name><name><surname>Brizard</surname><given-names>G</given-names></name><name><surname>Chemin</surname><given-names>K</given-names></name><name><surname>Boonstra</surname><given-names>A</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name><name><surname>Vicari</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Type I interferon dependence of plasmacytoid dendritic cell activation and migration</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>:<fpage>1157</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20041930</pub-id><?supplied-pmid 15795237?><pub-id pub-id-type="pmid">15795237</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longhi</surname><given-names>MP</given-names></name><name><surname>Trumpfheller</surname><given-names>C</given-names></name><name><surname>Idoyaga</surname><given-names>J</given-names></name><name><surname>Caskey</surname><given-names>M</given-names></name><name><surname>Matos</surname><given-names>I</given-names></name><name><surname>Kluger</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>:<fpage>1589</fpage>&#x02013;<lpage>602</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20090247</pub-id><?supplied-pmid 19564349?><pub-id pub-id-type="pmid">19564349</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>K</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Nakajima</surname><given-names>C</given-names></name><name><surname>Watanabe</surname><given-names>A</given-names></name><name><surname>Yanai</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2003</year>) <volume>100</volume>:<fpage>10872</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1934678100</pub-id><?supplied-pmid 12960379?><pub-id pub-id-type="pmid">12960379</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moltedo</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Yount</surname><given-names>JS</given-names></name><name><surname>Moran</surname><given-names>TM</given-names></name></person-group>. <article-title>Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection</article-title>. <source>PLoS Pathog</source> (<year>2011</year>) <volume>7</volume>:<fpage>e1002345</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1002345</pub-id><?supplied-pmid 22072965?><pub-id pub-id-type="pmid">22072965</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hervas-Stubbs</surname><given-names>S</given-names></name><name><surname>Perez-Gracia</surname><given-names>JL</given-names></name><name><surname>Rouzaut</surname><given-names>A</given-names></name><name><surname>Sanmamed</surname><given-names>MF</given-names></name><name><surname>Le Bon</surname><given-names>A</given-names></name><name><surname>Melero</surname><given-names>I</given-names></name></person-group>
<article-title>Direct effects of type I interferons on cells of the immune system</article-title>. <source>Clin Cancer Res</source> (<year>2011</year>) <volume>17</volume>:<fpage>2619</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-1114</pub-id><pub-id pub-id-type="pmid">21372217</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tough</surname><given-names>DF</given-names></name></person-group>
<article-title>Modulation of T-cell function by type I interferon</article-title>. <source>Immunol Cell Biol</source> (<year>2012</year>) <volume>90</volume>:<fpage>492</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/icb.2012.7</pub-id><pub-id pub-id-type="pmid">22391814</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bon</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>C</given-names></name><name><surname>Kamphuis</surname><given-names>E</given-names></name><name><surname>Durand</surname><given-names>V</given-names></name><name><surname>Rossmann</surname><given-names>C</given-names></name><name><surname>Kalinke</surname><given-names>U</given-names></name><etal/></person-group>
<article-title>Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<fpage>2074</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2074</pub-id><?supplied-pmid 16455962?><pub-id pub-id-type="pmid">16455962</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>WLW</given-names></name><name><surname>Coro</surname><given-names>ES</given-names></name><name><surname>Rau</surname><given-names>FC</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Erle</surname><given-names>DJ</given-names></name><name><surname>Baumgarth</surname><given-names>N</given-names></name></person-group>. <article-title>Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>1457</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.3.1457</pub-id><?supplied-pmid 17237394?><pub-id pub-id-type="pmid">17237394</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moseman</surname><given-names>EA</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>la Torre de</surname><given-names>JC</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name><name><surname>McGavern</surname><given-names>DB</given-names></name></person-group>
<article-title>Type I interferon suppresses virus-specific B cell responses by modulating CD8<sup>+</sup> T cell differentiation</article-title>. <source>Sci Immunol</source> (<year>2016</year>) <volume>1</volume>(<issue>4</issue>).<pub-id pub-id-type="doi">10.1126/sciimmunol.aah3565</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S</given-names></name><name><surname>McCabe</surname><given-names>TM</given-names></name><name><surname>Crotta</surname><given-names>S</given-names></name><name><surname>Gad</surname><given-names>HH</given-names></name><name><surname>Hessel</surname><given-names>EM</given-names></name><name><surname>Beinke</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>IFN&#x003bb; is a potent anti-influenza therapeutic without the inflammatory side effects of IFN&#x003b1; treatment</article-title>. <source>EMBO Mol Med</source> (<year>2016</year>) <volume>8</volume>:<fpage>1099</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="doi">10.15252/emmm.201606413</pub-id><?supplied-pmid 27520969?><pub-id pub-id-type="pmid">27520969</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>LM</given-names></name></person-group>. <article-title>The role of nuclear factor &#x003ba;B in the interferon response</article-title>. <source>J Interferon Cytokine Res</source> (<year>2011</year>) <volume>31</volume>:<fpage>553</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1089/jir.2011.0028</pub-id><?supplied-pmid 21631354?><pub-id pub-id-type="pmid">21631354</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>F</given-names></name><name><surname>Schiavoni</surname><given-names>G</given-names></name><name><surname>Tough</surname><given-names>DF</given-names></name></person-group>. <article-title>Regulation of immune cell homeostasis by type I interferons</article-title>. <source>Cytokine Growth Factor Rev</source> (<year>2010</year>) <volume>21</volume>:<fpage>227</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1016/j.cytogfr.2010.05.002</pub-id><?supplied-pmid 20627800?><pub-id pub-id-type="pmid">20627800</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>O</given-names></name><name><surname>Kochs</surname><given-names>G</given-names></name><name><surname>Weber</surname><given-names>F</given-names></name></person-group>. <article-title>The interferon response circuit: induction and suppression by pathogenic viruses</article-title>. <source>Virology</source> (<year>2006</year>) <volume>344</volume>:<fpage>119</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/j.virol.2005.09.024</pub-id><?supplied-pmid 16364743?><pub-id pub-id-type="pmid">16364743</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaitin</surname><given-names>DA</given-names></name><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>. <article-title>Upregulation of a small subset of genes drives type I interferon-induced antiviral memory</article-title>. <source>J Interferon Cytokine Res</source> (<year>2007</year>) <volume>27</volume>:<fpage>653</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1089/jir.2006.0162</pub-id><?supplied-pmid 17784817?><pub-id pub-id-type="pmid">17784817</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Channappanavar</surname><given-names>R</given-names></name><name><surname>Fehr</surname><given-names>AR</given-names></name><name><surname>Vijay</surname><given-names>R</given-names></name><name><surname>Mack</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Meyerholz</surname><given-names>DK</given-names></name><etal/></person-group>
<article-title>Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice</article-title>. <source>Cell Host Microbe</source> (<year>2016</year>) <volume>19</volume>:<fpage>181</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.01.007</pub-id><?supplied-pmid 26867177?><pub-id pub-id-type="pmid">26867177</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>BX</given-names></name><name><surname>Fish</surname><given-names>EN</given-names></name></person-group>. <article-title>The yin and yang of viruses and interferons</article-title>. <source>Trends Immunol</source> (<year>2012</year>) <volume>33</volume>:<fpage>190</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2012.01.004</pub-id><?supplied-pmid 22321608?><pub-id pub-id-type="pmid">22321608</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>KS</given-names></name><name><surname>Mossman</surname><given-names>KL</given-names></name></person-group>
<article-title>Viral evasion strategies in type I IFN signaling &#x02013; a summary of recent developments</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>459</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2016.00498</pub-id><pub-id pub-id-type="pmid">27833612</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coccia</surname><given-names>EM</given-names></name><name><surname>Battistini</surname><given-names>A</given-names></name></person-group>. <article-title>Early IFN type I response: learning from microbial evasion strategies</article-title>. <source>Semin Immunol</source> (<year>2015</year>) <volume>27</volume>:<fpage>85</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1016/j.smim.2015.03.005</pub-id><?supplied-pmid 25869307?><pub-id pub-id-type="pmid">25869307</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jewell</surname><given-names>NA</given-names></name><name><surname>Vaghefi</surname><given-names>N</given-names></name><name><surname>Mertz</surname><given-names>SE</given-names></name><name><surname>Akter</surname><given-names>P</given-names></name><name><surname>Peebles</surname><given-names>RS</given-names></name><name><surname>Bakaletz</surname><given-names>LO</given-names></name><etal/></person-group>
<article-title>Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo</article-title>. <source>J Virol</source> (<year>2007</year>) <volume>81</volume>:<fpage>9790</fpage>&#x02013;<lpage>800</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00530-07</pub-id><?supplied-pmid 17626092?><pub-id pub-id-type="pmid">17626092</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S</given-names></name><name><surname>Crotta</surname><given-names>S</given-names></name><name><surname>McCabe</surname><given-names>TM</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name></person-group>
<article-title>Pathogenic potential of interferon &#x003b1;&#x003b2; in acute influenza infection</article-title>. <source>Nat Commun</source> (<year>2014</year>) <volume>5</volume>:<fpage>3864</fpage><pub-id pub-id-type="doi">10.1038/ncomms4864</pub-id><pub-id pub-id-type="pmid">24844667</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cormier</surname><given-names>SA</given-names></name><name><surname>Shrestha</surname><given-names>B</given-names></name><name><surname>Saravia</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>GI</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>DeVincenzo</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title>Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection</article-title>. <source>J Virol</source> (<year>2014</year>) <volume>88</volume>:<fpage>9350</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00818-14</pub-id><?supplied-pmid 24920801?><pub-id pub-id-type="pmid">24920801</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remot</surname><given-names>A</given-names></name><name><surname>Descamps</surname><given-names>D</given-names></name><name><surname>Jouneau</surname><given-names>L</given-names></name><name><surname>Laubreton</surname><given-names>D</given-names></name><name><surname>Dubuquoy</surname><given-names>C</given-names></name><name><surname>Bouet</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV re-exposure in neonate mice</article-title>. <source>Eur J Immunol</source> (<year>2015</year>) <volume>46</volume>:<fpage>874</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201545929</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marr</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>TI</given-names></name><name><surname>Kam</surname><given-names>SHY</given-names></name><name><surname>Hu</surname><given-names>YS</given-names></name><name><surname>Sharma</surname><given-names>AA</given-names></name><name><surname>Lam</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>948</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1302007</pub-id><?supplied-pmid 24391215?><pub-id pub-id-type="pmid">24391215</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastings</surname><given-names>AK</given-names></name><name><surname>Erickson</surname><given-names>JJ</given-names></name><name><surname>Schuster</surname><given-names>JE</given-names></name><name><surname>Boyd</surname><given-names>KL</given-names></name><name><surname>Tollefson</surname><given-names>SJ</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication</article-title>. <source>J Virol</source> (<year>2015</year>) <volume>89</volume>:<fpage>4405</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.03275-14</pub-id><?supplied-pmid 25653440?><pub-id pub-id-type="pmid">25653440</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duerr</surname><given-names>CU</given-names></name><name><surname>McCarthy</surname><given-names>CDA</given-names></name><name><surname>Mindt</surname><given-names>BC</given-names></name><name><surname>Rubio</surname><given-names>M</given-names></name><name><surname>Meli</surname><given-names>AP</given-names></name><name><surname>Pothlichet</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<fpage>65</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3308</pub-id><?supplied-pmid 26595887?><pub-id pub-id-type="pmid">26595887</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeberle</surname><given-names>HA</given-names></name><name><surname>Takizawa</surname><given-names>R</given-names></name><name><surname>Casola</surname><given-names>A</given-names></name><name><surname>Brasier</surname><given-names>AR</given-names></name><name><surname>Dieterich</surname><given-names>H-J</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways</article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>186</volume>:<fpage>1199</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="doi">10.1086/344644</pub-id><?supplied-pmid 12402188?><pub-id pub-id-type="pmid">12402188</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stifter</surname><given-names>SA</given-names></name><name><surname>Bhattacharyya</surname><given-names>N</given-names></name><name><surname>Pillay</surname><given-names>R</given-names></name><name><surname>Fl&#x000f3;rido</surname><given-names>M</given-names></name><name><surname>Triccas</surname><given-names>JA</given-names></name><name><surname>Britton</surname><given-names>WJ</given-names></name><etal/></person-group>
<article-title>Functional interplay between type I and II interferons is essential to limit influenza A virus-induced tissue inflammation</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005378</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1005378</pub-id><?supplied-pmid 26731100?><pub-id pub-id-type="pmid">26731100</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermesh</surname><given-names>T</given-names></name><name><surname>Moltedo</surname><given-names>B</given-names></name><name><surname>Moran</surname><given-names>TM</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>CB</given-names></name></person-group>. <article-title>Antiviral instruction of bone marrow leukocytes during respiratory viral infections</article-title>. <source>Cell Host Microbe</source> (<year>2010</year>) <volume>7</volume>:<fpage>343</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2010.04.006</pub-id><?supplied-pmid 20478536?><pub-id pub-id-type="pmid">20478536</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlmeier</surname><given-names>JE</given-names></name><name><surname>Cookenham</surname><given-names>T</given-names></name><name><surname>Roberts</surname><given-names>AD</given-names></name><name><surname>Miller</surname><given-names>SC</given-names></name><name><surname>Woodland</surname><given-names>DL</given-names></name></person-group>. <article-title>Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>33</volume>:<fpage>96</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2010.06.016</pub-id><?supplied-pmid 20637658?><pub-id pub-id-type="pmid">20637658</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name></person-group>
<article-title>Type I IFN signaling facilitates the development of IL-10-producing effector CD8(+) T cells during murine influenza virus infection</article-title>. <source>Eur J Immunol</source> (<year>2016</year>) <volume>46</volume>(<issue>12</issue>):<fpage>2778</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201646548</pub-id><pub-id pub-id-type="pmid">27701741</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNally</surname><given-names>B</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Willette</surname><given-names>M</given-names></name><name><surname>Fla&#x000f1;o</surname><given-names>E</given-names></name></person-group>. <article-title>Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection</article-title>. <source>J Virol</source> (<year>2013</year>) <volume>87</volume>:<fpage>12916</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02423-13</pub-id><?supplied-pmid 24067957?><pub-id pub-id-type="pmid">24067957</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaperot</surname><given-names>L</given-names></name><name><surname>Blum</surname><given-names>A</given-names></name><name><surname>Manches</surname><given-names>O</given-names></name><name><surname>Lui</surname><given-names>G</given-names></name><name><surname>Angel</surname><given-names>J</given-names></name><name><surname>Molens</surname><given-names>J-P</given-names></name><etal/></person-group>
<article-title>Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<fpage>248</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.1.248</pub-id><?supplied-pmid 16365416?><pub-id pub-id-type="pmid">16365416</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herold</surname><given-names>S</given-names></name><name><surname>Steinmueller</surname><given-names>M</given-names></name><name><surname>Wulffen von</surname><given-names>W</given-names></name><name><surname>Cakarova</surname><given-names>L</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><name><surname>Pleschka</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand</article-title>. <source>J Exp Med</source> (<year>2008</year>) <volume>205</volume>:<fpage>3065</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20080201</pub-id><pub-id pub-id-type="pmid">19064696</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name></person-group>. <article-title><italic>Staphylococcus aureus</italic> induces type I IFN signaling in dendritic cells via TLR9</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>:<fpage>4040</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1201055</pub-id><?supplied-pmid 22962685?><pub-id pub-id-type="pmid">22962685</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Joyee</surname><given-names>AG</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Type I IFNs enhance susceptibility to <italic>Chlamydia muridarum</italic> lung infection by enhancing apoptosis of local macrophages</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>2092</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.3.2092</pub-id><?supplied-pmid 18641348?><pub-id pub-id-type="pmid">18641348</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Yeremeev</surname><given-names>V</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>J&#x000f6;rg</surname><given-names>S</given-names></name><name><surname>Heinemann</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>:<fpage>2380</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201344219</pub-id><?supplied-pmid 24782112?><pub-id pub-id-type="pmid">24782112</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MPR</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SAA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>:<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Oland</surname><given-names>SD</given-names></name><name><surname>Amaral</surname><given-names>EP</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Gonzales</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title>. <source>Nature</source> (<year>2014</year>) <volume>522</volume>:<fpage>99</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1038/nature13489</pub-id><?supplied-pmid 24990750?><pub-id pub-id-type="pmid">24990750</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>CE</given-names></name><name><surname>Harvey</surname><given-names>RM</given-names></name><name><surname>Plumptre</surname><given-names>CD</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name></person-group>
<article-title>Development of primary invasive pneumococcal disease caused by serotype 1 pneumococci is driven by early increased type I interferon response in the lung</article-title>. <source>Infect Immun</source> (<year>2014</year>) <volume>82</volume>:<fpage>3919</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.02067-14</pub-id><pub-id pub-id-type="pmid">25001606</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeMessurier</surname><given-names>KS</given-names></name><name><surname>H&#x000e4;cker</surname><given-names>H</given-names></name><name><surname>Chi</surname><given-names>L</given-names></name><name><surname>Tuomanen</surname><given-names>E</given-names></name><name><surname>Redecke</surname><given-names>V</given-names></name></person-group>. <article-title>Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003727</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003727</pub-id><?supplied-pmid 24244159?><pub-id pub-id-type="pmid">24244159</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Robinson</surname><given-names>KM</given-names></name><name><surname>McHugh</surname><given-names>KJ</given-names></name><name><surname>Scheller</surname><given-names>EV</given-names></name><name><surname>Mandalapu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source> (<year>2015</year>) <volume>309</volume>:<fpage>L158</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1152/ajplung.00338.2014</pub-id><?supplied-pmid 26001778?><pub-id pub-id-type="pmid">26001778</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>GT</given-names></name><name><surname>Davidson</surname><given-names>S</given-names></name><name><surname>Crotta</surname><given-names>S</given-names></name><name><surname>Branzk</surname><given-names>N</given-names></name><name><surname>Papayannopoulos</surname><given-names>V</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name></person-group>. <article-title>TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-<italic>Streptococcus pneumoniae</italic> coinfection</article-title>. <source>EMBO Rep</source> (<year>2015</year>) <volume>16</volume>:<fpage>1203</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.15252/embr.201540473</pub-id><?supplied-pmid 26265006?><pub-id pub-id-type="pmid">26265006</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Moltedo</surname><given-names>B</given-names></name><name><surname>Moran</surname><given-names>TM</given-names></name></person-group>
<article-title>Type I interferon induction during influenza virus infection increases susceptibility to secondary <italic>Streptococcus pneumoniae</italic> infection by negative regulation of &#x003b3;d T cells</article-title>. <source>J Virol</source> (<year>2012</year>) <volume>86</volume>:<fpage>12304</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01269-12</pub-id><pub-id pub-id-type="pmid">22951826</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahangian</surname><given-names>A</given-names></name><name><surname>Chow</surname><given-names>EK</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>JR</given-names></name><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title>. <source>J Clin Invest</source> (<year>2009</year>) <volume>119</volume>:<fpage>1910</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1172/JCI35412</pub-id><?supplied-pmid 19487810?><pub-id pub-id-type="pmid">19487810</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schliehe</surname><given-names>C</given-names></name><name><surname>Flynn</surname><given-names>EK</given-names></name><name><surname>Vilagos</surname><given-names>B</given-names></name><name><surname>Richson</surname><given-names>U</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Bosnjak</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>:<fpage>67</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3046</pub-id><?supplied-pmid 25419628?><pub-id pub-id-type="pmid">25419628</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Stavropoulos</surname><given-names>E</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Influenza A virus impairs control of <italic>Mycobacterium tuberculosis</italic> coinfection through a type I interferon receptor-dependent pathway</article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>209</volume>:<fpage>270</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit424</pub-id><?supplied-pmid 23935205?><pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G</given-names></name><name><surname>Braun</surname><given-names>M</given-names></name><name><surname>Staehli</surname><given-names>F</given-names></name><name><surname>Tardivel</surname><given-names>A</given-names></name><name><surname>Mattmann</surname><given-names>C</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<fpage>213</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.006</pub-id><?supplied-pmid 21349431?><pub-id pub-id-type="pmid">21349431</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meissner</surname><given-names>NN</given-names></name><name><surname>Swain</surname><given-names>S</given-names></name><name><surname>Tighe</surname><given-names>M</given-names></name><name><surname>Harmsen</surname><given-names>A</given-names></name><name><surname>Harmsen</surname><given-names>A</given-names></name></person-group>. <article-title>Role of type I IFNs in pulmonary complications of <italic>Pneumocystis murina</italic> infection</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>5462</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.9.5462</pub-id><?supplied-pmid 15843544?><pub-id pub-id-type="pmid">15843544</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>I</given-names></name><name><surname>Miyasaka</surname><given-names>T</given-names></name><name><surname>Zong</surname><given-names>T</given-names></name><etal/></person-group>
<article-title><italic>Cryptococcus neoformans</italic> infection in mice lacking type I interferon signaling leads to increased fungal clearance and IL-4-dependent mucin production in the lungs</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0138291</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0138291</pub-id><?supplied-pmid 26384031?><pub-id pub-id-type="pmid">26384031</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biondo</surname><given-names>C</given-names></name><name><surname>Midiri</surname><given-names>A</given-names></name><name><surname>Gambuzza</surname><given-names>M</given-names></name><name><surname>Gerace</surname><given-names>E</given-names></name><name><surname>Falduto</surname><given-names>M</given-names></name><name><surname>Galbo</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>566</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.1.566</pub-id><?supplied-pmid 18566423?><pub-id pub-id-type="pmid">18566423</pub-id></mixed-citation></ref></